We are live on
!
Find out more
HHMI
Howard Hughes Medical Institute Portfolio holdings
AUM
$416M
1-Year Est. Return
13.82%
This Fund
S&P 500
This Quarter
Est. Return
+5.46%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$630M
AUM Growth
+$164M
(+35%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
21.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$132M |
| 2 |
BIOA
BioAge Labs
BIOA
|
+$2.28M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.38% |
Similar funds
VM
SSC
I
ACM
MCM
MIA
FFA
SP
Howard Hughes Medical Institute's Q3 2024 Portfolio in Review
As of Q3 2024, Howard Hughes Medical Institute held 2 positions worth $630M, up 35% from $466M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Howard Hughes Medical Institute deployed $134M of net new capital in Q3 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was BioAge Labs: 113,765 shares worth $2.37M.
By sector, the portfolio is most concentrated in Healthcare at 0.38% of assets.
- Howard Hughes Medical Institute's largest Q3 2024 buy was BioAge Labs: 113,765 shares worth $2.37M.
- Howard Hughes Medical Institute added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $132M increase.
- Howard Hughes Medical Institute's ten largest holdings make up 100% of its $630M portfolio in Q3 2024.
- Howard Hughes Medical Institute opened 1 new position and closed 0 in Q3 2024.
- Howard Hughes Medical Institute's portfolio value rose 35% quarter-over-quarter to $630M.
Based on Howard Hughes Medical Institute's 13F filing for Q3 2024, filed 14 Nov 2024.